TVGN
Income statement / Annual
Last year (2025), Tevogen Bio Holdings Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Tevogen Bio Holdings Inc.'s net income was -$26.28 M.
See Tevogen Bio Holdings Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$509.20 K
|
$403.58 K
|
$378.36 K
|
$0.00
|
$0.00
|
| Gross Profit |
-$509.20 K
|
-$403.58 K
|
-$378.36 K
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$11.11 M
|
$31.03 M
|
$4.40 M
|
$0.00
|
$2.96 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.66 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$14.52 M
|
$22.13 M
|
$4.06 M
|
$953.08 K
|
$1.66 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$25.63 M
|
$53.16 M
|
$8.46 M
|
$953.08 K
|
$4.62 M
|
| Cost And Expenses |
$26.14 M
|
$53.56 M
|
$8.84 M
|
$953.08 K
|
$4.62 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$195.62 K
|
$184.04 K
|
$256.03 K
|
$0.00
|
$598.50 K
|
| Depreciation & Amortization |
$509.20 K
|
$403.58 K
|
$378.36 K
|
$0.00
|
$9.38 K
|
| EBITDA |
-$25.63 M |
-$13.14 M |
-$58.89 M |
$4.41 M |
-$14.99 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$134.92 K
|
$39.84 M
|
-$51.63 M
|
$5.36 M
|
-$10.98 M
|
| Income Before Tax |
-$26.28 M
|
-$13.73 M
|
-$60.48 M
|
$4.41 M
|
-$15.60 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$26.28 M
|
-$10.11 M
|
-$60.48 M
|
$4.41 M
|
-$15.60 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
| EPS |
-8.08 |
-4.68 |
-0.02 |
1.835 |
-16.5 |
| EPS Diluted |
-8.08 |
-4.68 |
-0.02 |
1.835 |
-16.5 |
| Weighted Average Shares Out |
$3.32 M
|
$2.93 M
|
$3.31 M
|
$2.40 M
|
$958.67 K
|
| Weighted Average Shares Out Diluted |
$3.32 M
|
$2.93 M
|
$3.31 M
|
$2.40 M
|
$958.67 K
|
| Link |
|
|
|
|
|
